Potential N-glycosylation sites and phosphorylation sites are marked by orange and red circles, respectively. Aspartic acid residue (dark blue circle) in TM3 and serine residue (light brown circle) in TM5 are putative residues that might chemically interact with 5-HT. The unique consensus sequence motif (PXXXWXPXF, dark brown circles) in aminergic receptors is conserved in TM6.
The motif (NPXXY, dark blue circles) is conserved in TM7 like other GPCRs. Two possible posttranslational palmitoylation cysteine residues (light yellow circles) and a PDZ-domain binding motif (ESFL, black circles) are also present in the C-terminal. Conserved motifs were determined using InterPro tool (https://www.ebi.ac.uk/interpro/) and Prosite (http://prosite.expasy.org/) whereas other residues and motifs were predicted using several tools from DTU bioinformatics. Supplementary Fig. 2 Potent screened chemicals from HB compounds with their chemical structures and respective median inhibitory concentrations (IC50). HB chemicals were injected in different doses (0, 0.01, 0.1, 1, and 10 µg/larva) along with a fixed 5-HT concentration (1 µg/larva) and FITC-tagged bacteria (500 cells/larva). After 15 min of treatment, hemocytes from treated larvae were collected in ACB followed by phagocytosis assay as described above. Percentages of phagocytosis against HB chemical treatment with increasing concentrations were calculated. Their IC50 values were determined using Probit analysis ( https://probitanalysis.wordpress.com ). Step 1 Synthesis of (S)-(-)-N-(t-butoxycarbonyl)-prolylglycine methylester (3) To a solution of (S)-(-)-N-(t-butoxycarbonyl)-proline 1 (5.00 g, 23.0 mmol) in CH2Cl2 (150 mL), amino acid methyl ester hydrochloride 2 (2.89 g, 23.0 mmol), 1-[3-(dimethylamino)propyl)]-3ethylcarbodiimide hydrochloride (5.34 g, 28.0 mmol), and 1-hydroxybenzotriazole monohydrate (3.77 g, 28.0 mmol) triethylamine (6.50 mL, 46.6 mmol) were added and the reaction mixture was stirred for 24 h at room temperature. The solvent was removed under reduced pressure. The residue was taken up in ethyl acetate (200 mL) and washed successively with water (200 mL), 1N HCl aqueous solution (200 mL), and sat. NaHCO3 aqueous solution (200 mL). The solvent was removed under reduced pressure to give (S)-(-)-N-(t-butoxycarbonyl)-prolylglycine methylester 3 as a white solid (4.82 g, 73%).
Step 2 Synthesis of (S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione (5) To a solution of (S)-(-)-N-(t-Butoxycarbonyl)-prolylglycine methylester 3 (4.80 g, 16.8 mmol) in CH2Cl2 (84 mL), trifluoroacetic acid (18.7 mL, 252.0 mmol) was added and the solution was stirred at room temp for 2 hr. The solvent was removed under reduced pressure. The residue was dissolved in MeOH (84 mL) and treated with triethylamine (9.3 mL, 67.2 mmol). The reaction mixture was kept under reflux overnight. The solvent was removed under reduced pressure and the oily residue was redissolved in ipropanol to give (S)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione 5 as a white solid (2.0 g, 78%).
Step 3
Synthesis of 2-chloro-N-(4-methoxyphenethyl)acetamide (7) To a solution of 2-chloroacetic acid 6 (3.00 g, 31.8 mmol) in CH2Cl2 (160 mL), 2-(4methoxyphenyl)ethylamine 7 (4.6 mL, 31.8 mmol) and N, N-diisopropylethylamine (8.45 mL, 63.5 mmol) were added and the reaction mixture was stirred for 15 min at room temperature. After addition of 1-[3-(dimethylamino)propyl)]-3-ethylcarbodiimide hydrochloride (7.30 g, 38.1 mmol) and 1hydroxybenzotriazole monohydrate (5.14 g, 38.1 mmol), the reaction mixture was stirred for 24 h at room temp. The reaction mixture was washed successively with 1 N HCl aqueous solution (160 mL) and sat. NaHCO3 aqueous solution (160 mL). The organic layer was dried over MgSO4, filtered, and concentrated. The residue was washed with diethyl ether to give 2-chloro-N-(4-methoxyphenethyl)acetamide 8 as a yellow solid (4.60 g, 63%).
Step 4 Synthesis of (S)-2-(1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-N-(4methoxyphenethyl)acetamide (9) To a solution of (S)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione 5 (1.00 g, 6.40 mmol) in THF (32 mL), portionwise 60 wt% NaH (260 mg, 6.40 mmol) at 0 o C was added and the reaction mixture was stirred 15 min at room temperature. 2-chloro-N-(4-methoxyphenethyl)acetamide 7 was added slowly to the reaction mixture then the mixture was stirred overnight at 65 o C. The reaction was monitored by TLC. The reaction mixture was quenched with sat. NH4Cl aqueous solution (100 mL) and extracted with EtOAc (2 X 100 mL). Combined organic layers were dried over MgSO4, filtered, and concentrated. The crude product was purified by silica-gel column chromatography (eluent: MeOH 10% in CH2Cl2) to give (S)-2-(1,4dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-N-(4-methoxyphenethyl)acetamide 9 as a yellow foam (1.74 g, 79%).
